AdaptHealth Corp. (AHCO)
- Previous Close
9.89 - Open
9.90 - Bid 7.18 x 100
- Ask 10.02 x 100
- Day's Range
9.85 - 9.99 - 52 Week Range
6.43 - 11.90 - Volume
65,414 - Avg. Volume
1,064,009 - Market Cap (intraday)
1.342B - Beta (5Y Monthly) 1.13
- PE Ratio (TTM)
-- - EPS (TTM)
-1.67 - Earnings Date Nov 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
11.39
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
adapthealth.comRecent News: AHCO
View MorePerformance Overview: AHCO
Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AHCO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AHCO
View MoreValuation Measures
Market Cap
1.33B
Enterprise Value
3.41B
Trailing P/E
--
Forward P/E
10.30
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.41
Price/Book (mrq)
0.88
Enterprise Value/Revenue
1.04
Enterprise Value/EBITDA
11.71
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.57%
Return on Assets (ttm)
4.11%
Return on Equity (ttm)
-12.88%
Revenue (ttm)
3.26B
Net Income Avi to Common (ttm)
-217.76M
Diluted EPS (ttm)
-1.67
Balance Sheet and Cash Flow
Total Cash (mrq)
102.3M
Total Debt/Equity (mrq)
142.94%
Levered Free Cash Flow (ttm)
240.27M